[Effect of immunosuppressive agents on nucleic acid and nucleotide metabolism in rheumatoid arthritis (experimental and clinical study)].
D000477:Alkylating Agents / Q000627:therapeutic use; D000818:Animals; D000906:Antibodies / Q000302:isolation & purification; D000963:Antimetabolites / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy* / Q000276:immunology; D004247:DNA / Q000378:metabolism*; D003851:Deoxyribonucleases / Q000378:metabolism*; D004359:Drug Therapy, Combination; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D012313:RNA / Q000378:metabolism*; D011817:Rabbits; D051381:Rats; D012260:Ribonucleases / Q000378:metabolism*; D013154:Spleen / Q000378:metabolism
D000477:Alkylating Agents; D000906:Antibodies; D000963:Antimetabolites; D007166:Immunosuppressive Agents; D012313:RNA; D004247:DNA; D003851:Deoxyribonucleases; D012260:Ribonucleases
Vliianie immunodepressantov na nukleinovyĭ i nukleotidnyĭ obmen pri revmatoidnom artrite (éksperimental'noe i klinicheskoe issledovanie)